Completed PHASE2/PHASE3 INTERVENTIONAL 3-arm NCT03167918

Lung Function in Patients With Early Type 2 Diabetes Mellitus

Liaoning University of Traditional Chinese Medicine

Sponsor: Liaoning University of Traditional Chinese Medicine

Conditions Pulmonary Function Type 2 Diabetes Mellitus

Interventions Calcium Dobesilate Mecobalamin Tablets Xuefuzhuyu Decoction Xuefuzhuyu Decoction & Calcium dobesilate metformin

Updated 5 times since 2017 Last updated: May 24, 2017 Started: Jul 21, 2014 Primary completion: Apr 1, 2017 Completion: May 1, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03167918, this PHASE2/PHASE3 trial focuses on Pulmonary Function and Type 2 Diabetes Mellitus and remains completed. Sponsored by Liaoning University of Traditional Chinese Medicine, it has been updated 5 times since 2014, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2/PHASE3

Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2_PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2_PHASE3
Jul 2017 — Jun 2018 [monthly]

Completed PHASE2_PHASE3

First recorded

Jul 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Liaoning University of Traditional Chinese Medicine

Data source: Liaoning University of Traditional Chinese Medicine

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.